Kevin W. Bailey

3.4k total citations
69 papers, 2.6k citations indexed

About

Kevin W. Bailey is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Kevin W. Bailey has authored 69 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Epidemiology, 29 papers in Infectious Diseases and 18 papers in Immunology. Recurrent topics in Kevin W. Bailey's work include Influenza Virus Research Studies (22 papers), Viral Infections and Outbreaks Research (20 papers) and Viral Infections and Vectors (18 papers). Kevin W. Bailey is often cited by papers focused on Influenza Virus Research Studies (22 papers), Viral Infections and Outbreaks Research (20 papers) and Viral Infections and Vectors (18 papers). Kevin W. Bailey collaborates with scholars based in United States, Japan and Hong Kong. Kevin W. Bailey's co-authors include Robert W. Sidwell, Donald F. Smee, Min‐Hui Wong, Yousuke Furuta, Brian B. Gowen, John D. Morrey, Dale L. Barnard, John H. Huffman, Kie‐Hoon Jung and Craig W. Day and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

In The Last Decade

Kevin W. Bailey

67 papers receiving 2.5k citations

Peers

Kevin W. Bailey
R. W. Sidwell United States
Rachel Williams United Kingdom
Wen‐Zhe Ho United States
James R. Lokensgard United States
Edmond J. Remarque Netherlands
Anna Albecka United Kingdom
Genya Gekker United States
Kevin W. Bailey
Citations per year, relative to Kevin W. Bailey Kevin W. Bailey (= 1×) peers Panyong Mao

Countries citing papers authored by Kevin W. Bailey

Since Specialization
Citations

This map shows the geographic impact of Kevin W. Bailey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin W. Bailey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin W. Bailey more than expected).

Fields of papers citing papers by Kevin W. Bailey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin W. Bailey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin W. Bailey. The network helps show where Kevin W. Bailey may publish in the future.

Co-authorship network of co-authors of Kevin W. Bailey

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin W. Bailey. A scholar is included among the top collaborators of Kevin W. Bailey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin W. Bailey. Kevin W. Bailey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Westover, Jonna B., Kevin W. Bailey, Alexander A. Kolykhalov, et al.. (2025). Effective treatment of advanced Oropouche virus, Rift Valley fever virus, and Dabie bandavirus infections with 4'-fluorouridine. mBio. 16(10). e0146725–e0146725.
2.
Williamson, Lauren E., Abhishek Bandyopadhyay, Kevin W. Bailey, et al.. (2023). Structural constraints link differences in neutralization potency of human anti-Eastern equine encephalitis virus monoclonal antibodies. Proceedings of the National Academy of Sciences. 120(13). e2213690120–e2213690120. 4 indexed citations
3.
Gowen, Brian B., Brady T. Hickerson, Joanne York, et al.. (2021). Second-Generation Live-Attenuated Candid#1 Vaccine Virus Resists Reversion and Protects against Lethal Junín Virus Infection in Guinea Pigs. Journal of Virology. 95(14). e0039721–e0039721. 21 indexed citations
4.
Gowen, Brian B., Jonna B. Westover, Eric J. Sefing, et al.. (2017). Enhanced protection against experimental Junin virus infection through the use of a modified favipiravir loading dose strategy. Antiviral Research. 145. 131–135. 15 indexed citations
5.
Scharton, Dionna, Arnaud J. Van Wettere, Kevin W. Bailey, et al.. (2015). Rift Valley Fever Virus Infection in Golden Syrian Hamsters. PLoS ONE. 10(1). e0116722–e0116722. 20 indexed citations
6.
Scharton, Dionna, Kevin W. Bailey, Jonna B. Westover, et al.. (2014). Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment. Antiviral Research. 104. 84–92. 83 indexed citations
7.
Kumaki, Yohichi, Miles K. Wandersee, Aaron Smith, et al.. (2011). Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin. Antiviral Research. 90(1). 22–32. 71 indexed citations
8.
Kumaki, Yohichi, Jane Ennis, Ramtin Rahbar, et al.. (2010). Single-dose intranasal administration with mDEF201 (adenovirus vectored mouse interferon-alpha) confers protection from mortality in a lethal SARS-CoV BALB/c mouse model. Antiviral Research. 89(1). 75–82. 34 indexed citations
9.
Barnard, Dale L., Craig W. Day, Kevin W. Bailey, et al.. (2008). Is the anti-psychotic, 10-(3-(dimethylamino)propyl)phenothiazine (promazine), a potential drug with which to treat SARS infections?. Antiviral Research. 79(2). 105–113. 14 indexed citations
10.
Barnard, Dale L., Craig W. Day, Kevin W. Bailey, et al.. (2006). Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin. Antiviral Research. 71(1). 53–63. 85 indexed citations
11.
Smee, Donald F., Min‐Hui Wong, Kevin W. Bailey, et al.. (2004). Effects of four antiviral substances on lethal vaccinia virus (IHD strain) respiratory infections in mice. International Journal of Antimicrobial Agents. 23(5). 430–437. 40 indexed citations
12.
Smee, Donald F., Kevin W. Bailey, & Robert W. Sidwell. (2003). Comparative Effects of Cidofovir and Cyclic HPMPC on Lethal Cowpox and Vaccinia Virus Respiratory Infections in Mice. Chemotherapy. 49(3). 126–131. 17 indexed citations
13.
Smee, Donald F., Kevin W. Bailey, Ann Morrison, & Robert W. Sidwell. (2002). Combination Treatment of Influenza A Virus Infections in Cell Culture and in Mice with the Cyclopentane Neuraminidase Inhibitor RWJ-270201 and Ribavirin. Chemotherapy. 48(2). 88–93. 41 indexed citations
14.
Smee, Donald F., Kevin W. Bailey, Min‐Hui Wong, & Robert W. Sidwell. (2001). Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice. Antiviral Research. 52(1). 55–62. 69 indexed citations
15.
Burger, Roger A., et al.. (2000). Immunological effects of the orally administered neuraminidase inhibitor oseltamivir in influenza virus-infected and uninfected mice. Immunopharmacology. 47(1). 45–52. 32 indexed citations
16.
Fatemi, S. Hossein, David A. Kist, R. W. Sidwell, et al.. (1999). Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice. Molecular Psychiatry. 4(2). 145–154. 190 indexed citations
17.
Fatemi, S. Hossein, Robert W. Sidwell, Jerry Sedgewick, et al.. (1998). Human influenza viral infection in utero increases nNOS expression in hippocampi of neonatal mice. Synapse. 29(1). 84–88. 44 indexed citations
18.
Fatemi, S. Hossein, Robert W. Sidwell, David A. Kist, et al.. (1998). Differential expression of synaptosome-associated protein 25 kDa [SNAP-25] in hippocampi of neonatal mice following exposure to human influenza virus in utero. Brain Research. 800(1). 1–9. 40 indexed citations
19.
Sidwell, Robert W., et al.. (1995). In vitro and in vivo Sensitivity of a Non-Mouse-Adapted Influenza A (Beijing) Virus Infection to Amantadine and Ribavirin. Chemotherapy. 41(6). 455–461. 23 indexed citations
20.
Harber, Philip, et al.. (1991). The structure of expert diagnostic knowledge in occupational medicine. American Journal of Industrial Medicine. 19(1). 109–120. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026